Patient belief in medicine is challenged, access to healthcare professionals is becoming more remote and patients are faced with multiple sources of complex and sometimes unreliable information.
Building patient trust in pharma is now more important than ever and a change in how pharma recognises and communicates patient value is imperative. This issue was full explored during our Paris and New Jersey Forums.
White Papers for both Paris 2022 and New Jersey 2023 in which our expert Renaissance forum examines the concept and needs for pharma to transform in order to build patient trust and belief in the value of medicines.
Click here for more information and to request a copy of the White Paper
